4765-6-05. Exposure to a nerve or organophosphate agent

An EMS provider, certified in accordance with section 4765.30 of the Revised Code and Chapter 4765-8 of the Administrative Code, may administer appropriate drugs in response to suspected or known exposure to a nerve or organophosphate agent provided the EMS provider is under physician medical direction and has received appropriate training regarding the administration of such drug. An emergency medical responder or emergency medical technician shall be limited to administration of such drugs from a pre-filled auto-injector.

Five Year Review (FYR) Dates: 1/11/2019 and 12/31/2023
Promulgated Under: 119.03
Statutory Authority: 4765.35, 4765.37, 4765.38, 4765.39, 4765.11
Rule Amplifies: 4765.35, 4765.37, 4765.38, 4765.39
Prior Effective Dates: 12/30/2004, 09/01/2005, 07/02/2009, 02/06/2012

Prior History: (R.C. 119.032 review dates: 03/14/2014 and 03/13/2019
Promulgated Under: 119.03
Statutory Authority: R.C. 4765.11, 4765.35, 4765.37, 4765.38, 4765.39
Rule Amplifies: R.C. 4765.35, 4765.37, 4765.38, and 4765.39
Prior Effective Dates: 12/30/04, 9/1/05, 7/2/09, 2/6/2012)